Discover 1,406 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,406
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: St Louis MO, Decatur IL, Peoria IL, Springfield MO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase 2, Recruiting
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl
for
Alzheimer Disease
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT06439992
Recruiting
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
for
Advanced Melanoma, Metastatic Melanoma
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT05629546
Phase 1, Recruiting
A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults
for
Respiratory Syncytial Virus (RSV)
Location: St Louis MO, Iowa City IA, Decatur GA, DeSoto TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07768345
Phase 3, Recruiting
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
for
Small Cell Lung Cancer (SCLC ),
Location: St Louis MO, Nashville TN, Dallas TX, Houston TX,
Sponsor: Moonlight Bio, Inc
Sex: All
Age: 18+
Code: NCT07488923
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Brain Organization, Development, and Response to Intervention in Individual Neonates
for
Development, Infant
Location: St Louis MO, Minneapolis MN
Sponsor: Washington University School of Medicine
Sex: All
Age: 0+
Code: NCT05843396
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Location: St Louis MO, Westwood KS, Fort Wayne IN, Tampa FL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06697184
Phase 1, Phase 2, Recruiting
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
for
Metastatic Colorectal Cancer
Location: St Louis MO, Chicago IL, Madison WI, Omaha NE,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07416552
Phase 1, Recruiting
DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
for
Small-cell Lung Cancer, Small Cell Lung Cancer Extensive Stage
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT07545954
Phase 1, Recruiting
Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
for
Multiple Sclerosis (MS) - Relapsing-remitting
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 40 - 70
Code: NCT07758270
Recruiting
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
for
Multiple Myeloma
Location: St Louis MO, Denver CO, Goodyear AZ, Irvine CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07589634
Phase 2, Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
for
Pulmonary Arterial Hypertension
Location: St Louis MO, Kansas City KS, Louisville KY, Chicago IL,
Sponsor: Gossamer Bio USA, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06274801
Phase 3, Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
for
Carcinoma, Renal Cell
Location: St Louis MO, Louisville KY, Germantown TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07489495
Phase 3, Recruiting
DAREONĀ®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: St Louis MO, Nashville TN, Knoxville TN, Atlanta GA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07544654
Phase 3, Recruiting
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
for
Metastatic Malignant Solid Neoplasm,
Location: St Louis MO, Chicago IL, Madison WI, Lexington KY,